All News | Regulatory

CONTROLLED SUBSTANCES NEWS

Apr 10, 2014
Industry Group Calls for Collaboration With DEA in Curbing Drug Diversion
Apr 3, 2014
DEA Sets Quotas for Designer Drugs
Mar 25, 2014
Update: More Than a Third of Pharmacies Now Accept EPCS
Mar 23, 2014
Disposal Rule Undergoing Final Review by OMB
Mar 20, 2014
Registration Revocation Actions: December 2013 to March 2014
Mar 18, 2014
New Insomnia Drug Proposed for Schedule IV
Mar 17, 2014
New Registration Number Series Applies to DoD Contractor Physicians, Other Practitioners
Mar 17, 2014
Alfaxalone Veterinary Anesthetic Is Placed in Schedule IV
Mar 12, 2014
‘Designer Drug’ Regulatory Catch-up Continues
Mar 10, 2014
Extended Release Hydrocodone Pain Drug, Zohydro, May Be Launched in March
Mar 7, 2014
Multi-Ingredient Hydrocodone Drugs Proposed for Transfer to Schedule II
Feb 21, 2014
House Bill Would Amend CSA to Help Ensure Patient Access, Prevent Diversion
Feb 7, 2014
Physician-owner of Alleged Bronx Pill Mill Arrested With Numerous Others in New York
Jan 24, 2014
Georgia Physician Convicted for Role in Pill Mill Operated by Florida Residents
Jan 9, 2014
Community Pharmacists Say Access to Controlled Substances Disrupted by Enforcement Efforts
Dec 23, 2013
Applications for Bulk Import/Manufacture: September-November 2013
Dec 9, 2013
Registration Revocation Actions: September to November 2013
Dec 4, 2013
New Seizure Therapy Drug Placed in Schedule III
Nov 29, 2013
Tramadol (Ultram) Proposed for Schedule IV
Nov 22, 2013
Abuse of Controlled Prescribed Substances Continues to Be Nation’s Fastest-Growing Drug Problem
Nov 14, 2013
FDA Proposes to Require Manufacturers to Report Discontinuance or Interruptions in Drug Supply
Nov 13, 2013
Legislative Fixes Needed to Improve Prosecutions on Designer Drugs, DEA Officials Say
Sep 20, 2013
Quotas: 2013 Adjustments, 2014 Proposed
Sep 19, 2013
Registration Revocation Actions: June 1 to Aug. 31, 2013
Sep 12, 2013
2014 Initial Aggregate Production Quotas Published

Copyright © Thompson Controlled Subtances, a division of CBIS. All rights reserved.